相关实验视频
Updated: Jul 6, 2025

A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
模型的开发和外部验证,以预测持续的低血症呼吸衰竭,用于临床试验丰富
Neha A Sathe1, Leila R Zelnick2, Eric D Morrell1
1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA.
使用常规ICU数据和免疫生物标志物的新模型可以预测持续的缺血性呼吸衰竭 (HRF) 风险,提高临床试验的效率. 这些模型有助于识别针对性治疗的高风险患者.
科学领域:
- 关键护理医学 关键护理医学
- 肺部医学 肺部医学
- 生物标志物研究 生物标志物研究
背景情况:
- 急性缺血性呼吸衰竭 (HRF) 在重症监护室 (ICU) 构成了重大挑战.
- 提高HRF的临床试验效率需要有效的患者丰富策略,以专注于患有持续性疾病高风险的人.
研究的目的:
- 开发和验证用于预测持续HRF风险的节模型.
- 利用常规ICU入院数据,并为风险预测选择免疫生物标志物.
主要方法:
- 预期推导 (n=630) 和成年ICU急性HRF患者的验证 (n=511) 队列.
- 使用LASSO回归的临床模型和结合IL-6的模型的开发.
- 与现有策略相比,对模型歧视,校准和实际实用性的评估.
主要成果:
- 持续的HRF分别发生在49%和69%的导出和验证集中.
- 在验证中,LASSO和LASSO + IL-6模型与单独的PaO2/FiO2 (AUC 0.64) 相比,显示出更高的歧视 (AUC 0.68和0.71).
- 两种开发的模型都显示出更好的实用实用性和样本大小节省,用于试验丰富.
结论:
- 节的,可解释的模型可以预测持续的HRF风险.
- 这些模型可以增强HRF向治疗的临床试验的丰富性.
- 这些预测模型的进一步验证是有必要的.
更多相关视频
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
04:10Author Spotlight: Exploring Venous Waveforms for Non-Invasive Respiratory Monitoring in Pigs
Published on: March 8, 2024
相关概念视频
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-IV
Acute Respiratory Failure-III